Our results confirmed the previous findings of Shien et al. [35], showing that the JAK family of tyrosine-kinases, especially JAK1, is a critical type of kinase that mediates the activation of STAT3 through IL-6 cytokines in NSCLC cells. The gene discussed is JAK1; the disease is non-small cell lung carcinoma.